Identity
- Security key
- 11744
- Ticker
- ANRO
- Type
- CS — Common Stock
- Exchange
- New York Stock Exchange(XNYS)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2024-02-02
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ANRO
Detail
Enriched 2026-08-14 20:47
- Market cap
- $1,134,237,571.68
- Shares outstanding (class)
- 35,093,940
- Shares outstanding (weighted)
- 38,870,376
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 68
- Location
- MOUNTAIN VIEW, CA
- Homepage
- https://www.altoneuroscience.com
- Description
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Market cap and share counts drift.